Baicalein Attenuates Eosinophilic Rhinosinusitis by Suppressing ALOX15-Mediated M2 Macrophage Function
Lei Wang, Zhenzhen Zhu, Yuzhuo Liu, Surita Aodeng, Tianhui Kang, Weiqing Wang, Wei Lv · 2026
Read Baicalein Attenuates Eosinophilic Rhinosinusitis by Suppressing ALOX15-Mediated M2 Macrophage Function by Lei Wang, Zhenzhen Zhu, Yuzhuo Liu, Surita Aodeng, Tianhui Kang, Weiqing Wang, Wei Lv (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13566850.txt.
Description
Lei Wang and co-authors test baicalein, a plant flavonoid, against eosinophilic chronic rhinosinusitis with nasal polyps, a stubborn type 2 inflammation of the nose. The diseased tissue is crowded with M2 macrophages, a wound-healing immune cell turned harmful here. The team focused on ALOX15, a fat-processing enzyme. Patient samples from healthy controls, non-eosinophilic disease, and eosinophilic disease were compared for the enzyme's level and location.
ALOX15 ran high in the eosinophilic tissue, and sat inside the M2 macrophages. In lab-grown M2 cells, switching the cells on raised ALOX15 and fat oxidation. Baicalein pushed both back down and cut the release of several immune signals. A known ALOX15 blocker was used to check the target. In mice, a papain-driven model of the disease was treated with baicalein, and nose tissue, IgE, and immune cell entry were scored.
Catalog record
| CREATOR | Lei Wang, Zhenzhen Zhu, Yuzhuo Liu, Surita Aodeng, Tianhui Kang, Weiqing Wang, Wei Lv |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |